Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics
Exicure (Nasdaq: XCUR) has appointed Anna Chukaeva as Senior Vice President, Head of Corporate Development and Bioinformatics. Anna will lead investments, acquisitions, and strategic partnerships, while also focusing on leveraging data and AI for drug discovery and diagnostics.
Anna's background includes co-founding Carta Healthcare, an AI healthcare data company that raised over $50 million in venture financing. At Carta, she led a 40-person engineering and product team, developing enterprise-scale data software products adopted by hospital systems nationwide. Anna holds a bachelor's degree in mathematics, a master's in economics, and an MBA from Stanford.
Exicure (Nasdaq: XCUR) ha nominato Anna Chukaeva come Vicepresidente Senior, Responsabile dello Sviluppo Aziendale e della Bioinformatica. Anna guiderà investimenti, acquisizioni e partnership strategiche, concentrandosi anche sull'utilizzo di dati e intelligenza artificiale per la scoperta di farmaci e la diagnostica.
Il background di Anna include la co-fondazione di Carta Healthcare, un'azienda di dati sanitari basata sull'intelligenza artificiale che ha raccolto oltre 50 milioni di dollari in finanziamenti di venture capital. Presso Carta, ha guidato un team di ingegneria e prodotto di 40 persone, sviluppando prodotti software per dati su scala aziendale adottati dai sistemi ospedalieri in tutto il paese. Anna ha conseguito una laurea in matematica, un master in economia e un MBA presso Stanford.
Exicure (Nasdaq: XCUR) ha nombrado a Anna Chukaeva como Vicepresidenta Senior, Jefa de Desarrollo Corporativo y Bioinformática. Anna dirigirá inversiones, adquisiciones y alianzas estratégicas, mientras se enfoca en aprovechar dati e inteligencia artificial para el descubrimiento de fármacos y diagnósticos.
La trayectoria de Anna incluye la cofundación de Carta Healthcare, una empresa de datos de salud basada en inteligencia artificial que recaudó más de 50 millones de dólares en financiación de riesgo. En Carta, lideró un equipo de ingeniería y producto de 40 personas, desarrollando productos de software de datos a escala empresarial adoptados por sistemas hospitalarios en todo el país. Anna posee una licenciatura en matemáticas, un máster en economía y un MBA de Stanford.
엑시큐어(나스닥: XCUR)는 안나 추카예바를 수석 부사장 겸 기업 개발 및 생물정보학 책임자로 임명했습니다. 안나는 투자, 인수 및 전략적 파트너십을 주도하며, 약물 발견 및 진단을 위한 데이터와 인공지능 활용에 중점을 둘 것입니다.
안나의 배경에는 5천만 달러 이상을 모금한 인공지능 헬스케어 데이터 회사인 카르타 헬스케어의 공동 설립이 포함됩니다. 카르타에서 그녀는 40명의 엔지니어링 및 제품 팀을 이끌었고, 전국 병원 시스템에서 채택된 기업 규모의 데이터 소프트웨어 제품을 개발했습니다. 안나는 수학 학사, 경제학 석사 및 스탠포드 MBA를 보유하고 있습니다.
Exicure (Nasdaq: XCUR) a nommé Anna Chukaeva au poste de Vice-Présidente Senior, Responsable du Développement Corporatif et de la Bioinformatique. Anna dirigera les investissements, les acquisitions et les partenariats stratégiques, tout en se concentrant également sur l'utilisation de données et d'IA pour la découverte de médicaments et le diagnostic.
Le parcours d'Anna inclut la co-fondation de Carta Healthcare, une entreprise de données de santé basées sur l'IA qui a levé plus de 50 millions de dollars en financement par capital-risque. Chez Carta, elle a dirigé une équipe d'ingénierie et de produit de 40 personnes, développant des produits logiciels de données à grande échelle adoptés par des systèmes hospitaliers à l'échelle nationale. Anna est titulaire d'une licence en mathématiques, d'un master en économie et d'un MBA de Stanford.
Exicure (Nasdaq: XCUR) hat Anna Chukaeva zur Senior Vice President, Leiterin der Unternehmensentwicklung und Bioinformatik ernannt. Anna wird Investitionen, Übernahmen und strategische Partnerschaften leiten und sich gleichzeitig darauf konzentrieren, Daten und KI für die Arzneimittelentdeckung und Diagnostik zu nutzen.
Annas Hintergrund umfasst die Mitgründung von Carta Healthcare, einem KI-gestützten Gesundheitsdatenunternehmen, das über 50 Millionen Dollar an Wagniskapital gesammelt hat. Bei Carta leitete sie ein 40-köpfiges Ingenieur- und Produktteam und entwickelte Unternehmenssoftwareprodukte, die in Krankenhaussystemen im ganzen Land eingeführt wurden. Anna hat einen Bachelor-Abschluss in Mathematik, einen Master-Abschluss in Wirtschaftswissenschaften und einen MBA von Stanford.
- Appointment of experienced executive with AI and healthcare data background
- Focus on leveraging data and AI for drug discovery and diagnostics
- Potential for strategic partnerships and acquisitions
- None.
Anna was the co-founder, President and COO of Carta Healthcare, an AI healthcare data company which has raised over
She received a bachelor’s degree in mathematics, a master’s in economics, and an MBA from Stanford.
About Exicure, Inc.
Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its recent restructuring and suspension of clinical and development activities, the Company is exploring strategic alternatives to maximize stockholder value, both with respect to its historical biotechnology assets and more broadly. For further information, see www.exicuretx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240808332746/en/
Josh Miller
847-673-1700
media@exicuretx.com
Source: Exicure, Inc.
FAQ
Who is the new Head of Corporate Development and Bioinformatics at Exicure (XCUR)?
What will be Anna Chukaeva's main responsibilities at Exicure (XCUR)?
What is Anna Chukaeva's background before joining Exicure (XCUR)?
What educational qualifications does Anna Chukaeva bring to her role at Exicure (XCUR)?
